| UHC Surest Medical and Drug | Vyjuvek® (Beramagene Geperpavec-Svdt) – Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Walkers - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Whole Exome and Whole Genome Sequencing (Non-Oncology Conditions) – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Xiaflex® (Collagenase Clostridium Histolyticum) – Commercial Medical Benefit Drug Policy | 2026-01-01 |
| Medicare NCD | NCD 240.9 - Noninvasive Positive Pressure Ventilation (NIPPV) in the Home for the Treatment of Chronic Respiratory Failure (CRF) Consequent to Chronic Obstructive Pulmonary Disease (COPD) | 2026-01-01 |
| Ambetter Health Florida Clinical | Experimental Technologies | 2026-01-01 |
| Ambetter Health Florida Clinical | Fertility Preservation | 2026-01-01 |
| Ambetter Health Florida Clinical | Gastric Electrical Stimulation | 2026-01-01 |
| Ambetter Health Florida Clinical | Implantable Hypoglossal Nerve Stimulation | 2026-01-01 |
| Ambetter Health Florida Clinical | Non-Myeloablative Allogeneic Stem Cell Transplants | 2026-01-01 |